Next-Gen Neurotechnologies: Graphene Electrodes and Magnetic Surgical Robotics in Deep Brain Neuromodulation
Dr. Dereck Mush, MD, MBA
Motif Neurotech
Developing implantable microstimulation devices to treat treatment-resistant depression.
What they do
The company designs a miniature, battery-free implant designed to reside under the scalp and deliver periodic neuromodulation to the prefrontal cortex. The system targets treatment-resistant depression by stimulating brain networks without requiring invasive brain surgery.
The record
- Vertical
- Neurotech
- Sub-segment
- Neuromodulation
- Product type
- Device
- Stage
- Series A
- Headquarters
- Houston, USA
- Region
- North America
- Founded
- 2022
- Total funding
- $19M raised
Notable investors: S3 Ventures, itsMR, Emmett & Associates.
Also in Neurotech
Related on The Signal
Dr. Dereck Mush, MD, MBA
The Skull as Therapeutic Infrastructure: How CraniUS and Chronic Convection Delivery Bypass the Blood-Brain Barrier
Dr. Dereck Mush, MD, MBA